Withings debuts ECG and SpO2-monitoring smartwatch at CES 2020

Withings debuted its ScanWatch at CES 2020.
Image: Withings

Notably, the 2020 Consumer Electronics Show has introduced the world to some decidedly large technical innovations. Sony shocked attendees by unveiling a stylish electric car. Similarly, Samsung revealed a host of products designed to transform analog dwellings into cutting-edge smart homes.

However, French electronics company Withings may have debuted the event’s most important new product. Indeed, the firm’s new ScanWatch has the potential to save the lives of undiagnosed cardiovascular disorder and sleep apnea patients.

Withings ScanWatch Features

Although there are many quality health trackers in the market, Withings ScanWatch provides its users with remarkably in-depth biometric data. Like many products of its type, the timepiece gathers information on users’ steps taken, sleep cycle, and heart rate. Moreover, the wearable also captures echocardiogram (ECG) information.

Manage your supply chain from home with Sourcengine

Consequently, the ScanWatch can detect if a user is experiencing arterial fibrillation (AFib), or irregular heart rate. As stated by the Mayo Clinic, AFib sufferers are at risk for severe medical complications such as stroke or heart failure. Unfortunately, the condition’s symptoms, such as dizziness and fatigue, are often dismissed as not being serious.

Thanks to its medical-grade ECG, the ScanWatch can recognize AFib and alert users to seek immediate medical attention.

Withings' SnanWatch is a CES 2020 Innovation Award Honoree.
Image: Withings

Similarly, Withings latest health tracker also can trace a wearer’s peripheral capillary oxygen saturation (spO2) levels. As such, the device can detect if the user has sleep apnea, a disorder that causes sufferers to stop breathing while at rest.

According to the American Sleep Apnea Association, an estimated 22 million Americans are currently living with the disorder. However, the organization also notes around 80 percent of people suffering from the condition don’t realize they have it. Worryingly, sleep apnea patients often develop complications such as hypertension, heart disease, and type 2 diabetes.

Because Withings equipped its ScanWatch with an sp02 monitor, it can detect apneic sleep episodes and help users get properly diagnosed. Although the firm’s latest timepiece won’t be available for sale until Q2 2020, it’s already secured a significant accolade. The Consumer Technology Association named the quality of life improving device as a CES 2020 Innovation Award Honoree.

Cutting Edge Innovation, Old-School Style

Although Withings designed the ScanWatch to serve as a medical-grade health tracker, it’s also an incredibly stylish smartwatch.

For one thing, the firm has pared its innovative timepiece with a host of different watchband options. Users can personalize their device with a stripe of soft silicone or a more refined leather band. Moreover, the tracker doesn’t look like most smartwatches. Its display features a tasteful sapphire glass clock face with a PMOLED insert and a stainless steel case. The small but sharp screen can present health data as well as notifications.

Though its crisp design should attract consumers of all backgrounds, the ScanWatch could interest an underserved demographic. As the health tracker resembles a classical timepiece, it could appeal to individuals who are put off by futuristic smartwatch form factors. Besides, the device is water-resistant up to 50 meters (164 feet) and runs 30 days between charges.

Furthermore, Withings will release two versions of the ScanWatch this year. The 38 mm edition of the timepiece will retail for $249 while its 42 mm counterpart costs $299. As such, the electronics company is offering consumers a multifaceted device at a reasonable price.


Please enter your comment!
Please enter your name here